Technology | Cath Lab | May 16, 2017

Adept Medical Launches IR Platform

Platform provides an over-patient work surface for vascular and interventional radiology

Adept Medical Launches IR Platform, interventional radiology

May 16, 2017 — Adept Medical announced the launch of the IR Platform, designed as an over-patient work surface for vascular and interventional radiology. The platform provides clinical benefits to the current practice of laying procedural equipment over the patient’s legs by offering a stable, radiolucent, height- and length-appropriate solution for femoral artery access procedures. It offers a stable solution for catheter/guide wire manipulation, with a large work area for equipment.

The height of the platform can be adjusted to suit the specific patient size, ensuring the surface’s feathered leading edge can be tuned to the femoral access site. The platform, with its attachable extension, can be set up at two different lengths according to equipment needs.

The stand-alone platform is well suited for shorter wire procedures such as rapid exchange catheter systems and the extended platform is suited for over-the-wire catheter systems or neuro radiology wires.

Placed over the patient’s legs once they are in a supine position on the imaging table, the carbon fiber composite is light, radiolucent, strong and easy to set up for each patient. For restless patients it can also be locked down, ensuring their movement will not dislodge the platform.

The IR Platform will be available for purchase June 1, 2017.

For more information: www.adeptmedical.co.nz

Related Content

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Overlay Init